Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» No, The New Cholesterol Drugs From Sanofi And Amgen Aren't Going To Cost $150 Billion A Year
No, The New Cholesterol Drugs From Sanofi And Amgen Aren't Going To Cost $150 Billion A Year
No, The New Cholesterol Drugs From Sanofi And Amgen Aren't Going To Cost $150 Billion A Year
Submitted by
admin
on February 19, 2015 - 7:53am
Source:
Forbes
News Tags:
Sanofi
Amgen
PCSK9 inhibitors
drug pricing
Headline:
No, The New Cholesterol Drugs From Sanofi And Amgen Aren't Going To Cost $150 Billion A Year
Do Not Allow Advertisers to Use My Personal information
